| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 552 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 397 | 2022 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 121 | 2023 |
| Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier S Vafaei, A Zekiy, R Khanamir, B Zaman, A Ghayourvahdat, ... Cancer Cell International 22 (2), 2022 | 111 | 2022 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 101 | 2022 |
| Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 AM Thomson, TA McHugh, AP Oron, C Teply, N Lonberg, VV Tella, ... The Lancet Haematology 10 (8), e585-e599, 2023 | 85 | 2023 |
| An updated systematic review on the effects of aerobic exercise on human blood lipid profile RI Doewes, G Gharibian, BA Zaman, R Akhavan-Sigari Current problems in cardiology 48 (5), 101108, 2023 | 56 | 2023 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 51 | 2023 |
| Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review S Shokravi, V Borisov, BA Zaman, F Niazvand, R Hazrati, MM Khah, ... Stem Cell Research & Therapy 13 (1), 192, 2022 | 35 | 2022 |
| Hepcidin as a diagnostic biomarker of iron deficiency anemia during pregnancy B Zaman, S Rasool, S Jasim, D Abdulah The Journal of Maternal-Fetal & Neonatal Medicine 34 (8), 1288-1296, 2021 | 23 | 2021 |
| CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool S Shojaei Baghini, ZR Gardanova, SAH Abadi, BA Zaman, A İlhan, ... Cellular & Molecular Biology Letters 27 (1), 35, 2022 | 16 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet, 2024 | 15 | 2024 |
| Prevalence of thyroid dysfunctions in a large, unselected population in Duhok city, Iraqi Kurdistan: A cross-sectional study B Zaman, SO Rasool, SM Sabri, GAM Raouf, AA Balatay, MA Abdulhamid, ... Journal of Biological Research-Bollettino Della Società Italiana Di Biologia …, 2021 | 10 | 2021 |
| Serum zinc levels in iron deficiency anemia, non-iron deficiency anemia, and normal pregnant women and its correlation with iron status and hematological parameters SO Rasool, BA Zaman, DM Abdulah Medical Journal of Babylon 17 (1), 103-108, 2020 | 7 | 2020 |
| The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study MR Malekpour, M Abbasi-Kangevari, SH Ghamari, J Khanali, ... EClinicalMedicine 60, 2023 | 6 | 2023 |
| SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis SA Mozaffari, A Salehi, E Mousavi, BA Zaman, AE Nassaj, ... Pathology-Research and Practice 239, 154131, 2022 | 6 | 2022 |
| Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major BA Zaman, SO Rasool, MA Merza, DM Abdulah Transfusion Clinique et Biologique 29 (2), 153-160, 2022 | 5 | 2022 |
| Hepcidin-to-ferritin ratio as an early diagnostic index of iron overload in β-thalassemia major patients BA Zaman, SA Ibrahim Hemoglobin 46 (2), 106-113, 2022 | 5 | 2022 |
| The effect of erythroferrone suppression by transfusion on the erythropoietin–erythroferrone–hepcidin axis in transfusion‐dependent thalassaemia: A pre–post cohort study BA Zaman, SO Rasool, JM Abdo British Journal of Haematology 201 (3), 547-551, 2023 | 3 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … F Alize J, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... Elsevier, 2024 | | 2024 |
Suzan Omer RasoolDepartment of Pharmacology and Clinical Pharmacy, University of Duhok, Kurdistan Region, Iraq.Verified email at uod.ac
